Hubei Goto Biopharm Co.,Ltd. (SHE:300966)
China
· Delayed Price · Currency is CNY 15.42
-0.24 (-1.53%)
Apr 25, 2025, 10:45 AM CST
Hubei Goto Biopharm Market Cap
Hubei Goto Biopharm has a market cap or net worth of 1.80 billion as of April 24, 2025. Its market cap has decreased by -7.37% in one year.
Market Cap
1.80B
Enterprise Value
2.88B
Revenue
536.60M
Ranking
n/a
PE Ratio
n/a
Stock Price
15.42
Market Cap Chart
Since April 9, 2021, Hubei Goto Biopharm's market cap has decreased from 6.57B to 1.80B, a decrease of -72.66%. That is a compound annual growth rate of -27.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2025 | 1.80B | -3.41% |
| Dec 31, 2024 | 1.86B | -29.78% |
| Dec 29, 2023 | 2.65B | -14.93% |
| Dec 30, 2022 | 3.11B | -34.18% |
| Dec 31, 2021 | 4.73B | -28.02% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 312.65B |
| Shenzhen Mindray Bio-Medical Electronics | 261.25B |
| WuXi AppTec | 153.67B |
| Zhangzhou Pientzehuang Pharmaceutical., | 124.28B |
| Aier Eye Hospital Group | 119.65B |
| Shanghai United Imaging Healthcare | 105.56B |
| Sichuan Biokin Pharmaceutical | 104.93B |
| Yunnan Baiyao Group Co.,Ltd | 102.08B |